A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users.

Ruben L.J. Osnabrugge,Stuart J. Head,Felix Zijlstra,Jurrien M. Ten Berg,Myriam Hunink,A. Pieter Kappetein,A. Cecile J. W. Janssens

A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users.

2015

Ruben L.J. Osnabrugge
Stuart J. Head
Felix Zijlstra
Jurrien M. Ten Berg
Myriam Hunink
A. Pieter Kappetein
A. Cecile J. W. Janssens

A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users

Keywords:

Medicine
Pharmacogenomics
Pathology
Clopidogrel
Coronary artery disease
Genotype
Pharmacology
Physical therapy
CYP2C19
Alternative medicine
cyp2c19 genotype
Surgery
critical assessment
Intensive care medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations